JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosein, E. A.
Right arrow Articles by Ara, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosein, E. A.
Right arrow Articles by Ara, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 230-232, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


THE INFLUENCE OF PENTOBARBITAL AND ETHER NARCOSIS ON THE BRAIN CONCENTRATION OF VARIOUS ESTERS WITH ACETYLCHOLINE ACTIVITY

E. A. Hosein 1 and Roushan Ara 1

1 Department of Biochemistry, McGill University, Montreal, Canada

Paper chromatographic analysis of extracts of rat brain, followed by biological assay with the frog rectus preparation of the eluates of specific bands from the chromatograms, showed that the administration of either pentobarbital or ether to produce deep anesthesia in these animals, caused a significant increase of the acetylcholine activity in the brain. This increased acetylcholine activity was, perhaps, mainly due to the increased concentration of either one or several of the CoA ester derivatives of gamma-butyrobetaine, crotonbetaine and carnitine.

Submitted on July 3, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.